Abstract
and high risk in 31 (38%), 43 (53%), and 7 (9%) pts, respectively. Median prescription dose was 50.4 Gy in 1.8 Gy fractions. The observed 10-year rate of IHD was 1.4% (95% CI Z 0.2-9.4). MRE for IHD with ABC and FB were 3.56% (95% CI Z 2.78-4.33) and 4.31% (95% CI Z 3.35-5.28), respectively [Table]. Cardiac testing was performed in 15 (19%) pts due to signs and symptoms of IHD: 1 of 3 pts had occlusive CAD on angiography, 1 of 7 pts had ischemic signs on stress testing, and 8 pts had normal stress myocardial perfusion single photon emission tomography (SPECT) imaging. Conclusions: The rate of IHD at 10 years was 1.4% in this first report of cardiac outcomes following RT with ABC. While limited by small study size, the low prevalence of abnormal cardiac testing corroborates findings. Using MRE, RT with ABC reduces the risk of IHD when compared to FB with the largest benefit observed for AHA high-risk pts. In appropriately selected pts, RT with ABC can provide a clinically significant reduction in the risk of IHD in survivors of LBC. Author Disclosure: H.B. Eldredge-Hindy: None. D. Duffy: None. K. Yamoah: None. A.P. Dicker: None. J. Skowronski: None. N.L. Simone: None. P.R. Anne: None.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: International Journal of Radiation Oncology*Biology*Physics
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.